Powder: -20°C for 3 years | In solvent: -80°C for 1 year
ACC-789 (NVP-ACC789 (ZK202650); ZK-202650) is an effective, specific and orally active inhibitor of the VEGF receptor tyrosine kinases.
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
5 mg | 在庫あり | ¥ 9,000 | |||
10 mg | 在庫あり | ¥ 15,000 | |||
25 mg | 在庫あり | ¥ 20,500 | |||
50 mg | 在庫あり | ¥ 35,500 | |||
100 mg | 在庫あり | ¥ 52,500 | |||
1 mL * 10 mM (in DMSO) | 在庫あり | ¥ 10,000 |
説明 | ACC-789 (NVP-ACC789 (ZK202650); ZK-202650) is an effective, specific and orally active inhibitor of the VEGF receptor tyrosine kinases. |
ターゲット&IC50 | VEGFR1 (human):0.38μM, PDGFRβ:1.4 μM, VEGFR3:0.18μM, VEGFR2 (mouse):0.23μM, VEGFR2 (human):0.02μM |
別名 | ACC-789, ZK202650 |
分子量 | 405.29 |
分子式 | C21H17BrN4 |
CAS No. | 300842-64-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 60 mg/mL (148.04 mM), Sonication and heating are recommended.
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
NVP-ACC789 300842-64-2 Angiogenesis Tyrosine Kinase/Adaptors PDGFR VEGFR ACC-789 NVP ACC789 Platelet-derived growth factor receptor inhibit NVPACC789 Inhibitor NVP-ACC-789 ACC 789 Vascular endothelial growth factor receptor ZK 202650 ACC789 ZK-202650 ZK202650 NVP-ACC 789 inhibitor